drug · antibody
patient view →tildrakizumab
pre_registrationupdated 2mo agoby Sun Pharmaceutical Industries Ltd🔗 ChEMBL
community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 3 investigational indications.
targets
Interleukin-23
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that